Status:

RECRUITING

HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs

Lead Sponsor:

IRCCS National Neurological Institute "C. Mondino" Foundation

Conditions:

Migraine Disorders

Chronic Migraine

Eligibility:

All Genders

18-65 years

Brief Summary

Migraine is a leading cause of disability with an estimated prevalence of 12% in Europe. The headache field witnessed a breakthrough since the introduction of specific preventive therapies which prove...

Detailed Description

Electroencephalogram (EEG) is widely available as a powerful mean to non-invasively study brain connectivity features in migraine patients. High density EEG, by means of a minimum of 64 up to 256 elec...

Eligibility Criteria

Inclusion

  • Episodic or chronic migraine diagnosis according to ICHD-3 criteria
  • Indication to BoNT-A or mAbs treatment according to AIFA criteria
  • Brain MRI performed within 24 months from enrolment

Exclusion

  • Previous or actual history of epilepsy
  • Diagnosis of dementia o mental retardation
  • Diagnosis of psychiatric illness according to Diagnostic and Statistical Manual of Mental Disorders V
  • Other concomitant type of headache (except for sporadic tension type headache)
  • Chronic pain conditions
  • Pregnancy or breastfeeding
  • Concomitant use of electrical stimulators, pace-makers, metallic clips or other metallic foreign bodies
  • Previous head surgery
  • Ongoing neuroactive prevention therapies or other drugs, or psicoactive substances possibly interfering with EEG recording (eg benzodiazepines)
  • Other conditions possibly influencing EEG recording
  • Brain anomalies detected on MRI

Key Trial Info

Start Date :

January 14 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06155123

Start Date

January 14 2020

End Date

June 1 2024

Last Update

January 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Headache Science & Neurorehabilitation Center

Pavia, Italy, 27100